Por: New York Post Business November 15, 2023
Problems are piling up at Walgreens — not least among them a bizarre, $200 million legal tussle with one of the drugstore giant’s vendors that has become “very awkward” for the company’s 82-year-old chairman, The Post has learned. Billionaire Stefano Pessina — whose Walgreens Boots Alliance disclosed last week it will lay off 5% of corporate staff as it and a — is meanwhile caught in the middle of an ugly lawsuit from Cooler... + full article
Fox Business USA Business October 04, 2023
St. Joseph Health Institute Director Dr. Bob Lahita reacts to the World Health Organization saying healthy kids and teens no longer need a COVID vaccine on 'Varney & Co.' Walgreens is adjusting its availability in response to ongoing appointment disruptions, a company... + más
Opioid legal charge pushes Walgreens to $3.7B fiscal 1Q loss | ABC News
Walgreens CEO Roz Brewer steps down after more than two years in the role | NBC News
Fox Business USA Business May 18, 2023
Telsey Advisory Group CEO Dana Telsey and Tigress Financial Partners CIO Ivan Feinseth discuss whether inflation is finally forcing consumers to pull back on spending on 'The Claman Countdown.' has agreed to pay San Francisco nearly $230 million to settle a lawsuit for... + más
Walgreens agrees to pay San Francisco nearly $230 million to settle opioid lawsuit | Los Angeles Times
Los Angeles Times USA Business March 08, 2023
When the U.S. Food and Drug Administration announced earlier this year that it would allow drugstore chains to sell mifepristone, the highly regulated first drug taken in a two-drug regimen for medication abortion, Walgreens and other pharmacy chains eagerly stepped up and said... + más
California to end Walgreens contract after company said it won’t sell abortion pill by mail in 20 states | Orlando Sentinel
California to end Walgreens contract after abortion dispute | ABC News
ABC News USA Business January 05, 2023
A huge opioid settlement dragged Walgreens to a $3.7 billion loss in its fiscal first quarter, but the drugstore chain still beat Wall Street forecasts.The company also reaffirmed its earnings forecast for the new year.Walgreens said Thursday that it recorded a $5.2 billion,... + más
Opioid legal charge pushes Walgreens to $3.7B fiscal 1Q loss | Associated Press
CVS, Walgreens agree to settle opioid lawsuits for a combined $10B | WGN-TV
Associated Press USA Business January 05, 2023
A huge opioid settlement dragged Walgreens to a $3.7 billion loss for the first quarter, but the drugstore chain still beat Wall Street forecasts.The company also reaffirmed its earnings forecast for the new year.Walgreens said Thursday that it recorded a $5.2 billion, after-tax... + más
CNBC USA Business October 13, 2022
on Thursday exceeded fiscal fourth quarter sales and earnings expectations, as the drugstore chain turns itself into a more health-care focused company.The company said it anticipates full-year adjusted earnings per share of $4.45 to $4.65 in the coming fiscal year, which is... + más
Walgreens beats fiscal 4Q forecasts, absorbs UK business hit | Orlando Sentinel
Walgreens says staffing shortages hit prescription growth | Fox Business
Orlando Sentinel USA Business October 13, 2022
Walgreens Boots Alliance topped earnings forecasts in the final quarter of fiscal 2022, and the drugstore chain’s early look at 2023 also fell mostly above expectations. A drop in COVID-19 vaccinations and a big charge tied to the company’s United Kingdom stores weighed on... + más
Walgreens beats sales expectations, as it expands its health-care business | CNBC
About iurex | Privacy Policy | Disclaimer |